Pharmaceutical Executive: April 2025 Interactive Digital Edition
View the Pharmaceutical Executive April 2025 issue in an interactive format.
‘Earning’ Power
The job of pharma-driven messaging and reputation management may never be more important than it is today.
Milan Kalawadia: Carving Out New Pathways
Milan Kalawadia, CEO, North America, at Dr. Reddy’s Laboratories, goes inside the company’s new growth initiatives—and stretching the boundaries in healthcare exploration.
Bringing Biotech Innovation Across Borders
Four tips for midsized companies when entering new global markets.
Using AI to Predict Launch Success
How to maximize market-entry performance for new pharma products in an increasingly competitive launch environment.
Improving Your Earned Media Strategy: Tips and Insights
Introducing a new series highlighting ways pharma companies can up their game in winning earned media—and ultimately deliver greater impact and value from their messaging.
The Future of DTC in Pharma
Sonam Dubey, a partner at Beghou Consulting, discusses the potential impact of a possible ban on direct-to-consumer advertising amid policy and government agency overhauls in the US.
Maintaining Supply Chain Resiliency, No Matter the Circumstances
The formula for future-proofing pharmaceutical networks to withstand any disruption.
Translating ‘Digital-First’ to Commercial Success
Why a fundamental rethinking of how manufacturers engage with healthcare providers, payers, and patients is necessary in today's pharma landscape.
HEOR: From Proving Product Value to Proving Its Own Worth
The recent shift in Health Economics and Outcomes Research functions across major pharmaceutical companies highlights a lack of understanding of its value.
